The growing economical, psychological and clinical burden of mental health, addiction, and chronic pain needs to be addressed. Our mission is to bridge the gap between what the system currently provides and what patients need. We are creating the future of integrative wellness, now.
Lost economic output due to mental health, substance use, and chronic pain disorders
Value of the global psychedelic market
Increase in opioid-related deaths over the course of the first six months of the pandemic
The average time that passes between illicit drug overdose deaths in Canada
1 in 4
Canadians aged 15 or older living with chronic pain
Relapse rate for current recovery models
1 in 2
People meet the criteria for at least one mental or substance use disorder by the age of 40
Levitee Labs Signs Letter of Intent to Acquire a Chain of Specialty Addiction Pharmacies Located in British ColumbiaLearn more
Levitee Labs looking to fuel revenue growth with rapid national acquisition strategy
Levitee Labs adds to portfolio acquiring Calgary Addiction and Compounding Pharmacy
My LARGEST Psychedelic Investment | $15M Revenue, $1.4M EBITDA in 2021! This Will Be HUGE.